Literature DB >> 32633664

Psycho-Social Correlates of Opioid Use Disorder among the US Adult Population: Evidence from the National Survey on Drug Use and Health, 2015-2018.

Mohammad Rifat Haider1, Monique J Brown2,3, Rajat Das Gupta2, Sabrina Karim2, Bankole Olatosi4, Xiaoming Li3,5.   

Abstract

BACKGROUND: The United States (US) has experienced an opioid epidemic over the last two decades. Drug overdose deaths increased by 21% from 2015 to 2016, with two-thirds of these deaths attributed to opioid use disorder (OUD). This study assessed the psycho-social correlates associated with OUD over 2015-2018 in the US.
Methods: This study used data collected from 171,766 (weighted = 245,838,163) eligible non-institutionalized US adults in the pooled National Survey on Drug Use and Health from 2015-2018. Survey-weighted descriptive, bivariate, and multivariable analyses were performed to assess the psycho-social correlates of OUD.
Results: About 0.85% of the respondents reported having OUD in the past year. About one-quarter (26.3%), one-sixth (14.8%), and half (47.3%) of the respondents with OUD reported alcohol, marijuana, and nicotine dependence, respectively. One-sixth (16.7%) had a criminal justice involvement history, and almost one-third (30.8%) experienced a major depressive episode (MDE) in the past year. In multivariable analysis, ≤64 years, White race, male gender, lower educational attainment, unemployment, large metro area residence, history of alcohol, marijuana, nicotine use disorder, history of criminal justice involvement, and MDE in previous year were associated with higher odds of OUD. In contrast, being married, non-Hispanic African American, non-Hispanic Other, and Hispanic ethnicity, good physical health, private health insurance, and higher risk perception about addictive substance use were associated with lower odds of OUD. Conclusions: OUD is more prevalent among certain sociodemographic groups in the US. Targeted interventions focusing on young, White, unmarried, male, and uninsured/Medicaid/Medicare populations should be implemented to reduce the OUD.

Entities:  

Keywords:  Opioid use disorder; USA; alcohol use disorder; criminal justice involvement; major depressive episode; marijuana use disorder; nicotine dependence

Mesh:

Substances:

Year:  2020        PMID: 32633664      PMCID: PMC7952032          DOI: 10.1080/10826084.2020.1788086

Source DB:  PubMed          Journal:  Subst Use Misuse        ISSN: 1082-6084            Impact factor:   2.164


  37 in total

1.  Depression and prescription opioid misuse among chronic opioid therapy recipients with no history of substance abuse.

Authors:  Alicia Grattan; Mark D Sullivan; Kathleen W Saunders; Cynthia I Campbell; Michael R Von Korff
Journal:  Ann Fam Med       Date:  2012 Jul-Aug       Impact factor: 5.166

2.  Cannabinoid and heroin activation of mesolimbic dopamine transmission by a common mu1 opioid receptor mechanism.

Authors:  G Tanda; F E Pontieri; G Di Chiara
Journal:  Science       Date:  1997-06-27       Impact factor: 47.728

3.  Macroeconomic conditions and opioid abuse.

Authors:  Alex Hollingsworth; Christopher J Ruhm; Kosali Simon
Journal:  J Health Econ       Date:  2017-08-23       Impact factor: 3.883

Review 4.  Prescription opioid abuse, pain and addiction: clinical issues and implications.

Authors:  Walter Ling; Larissa Mooney; Maureen Hillhouse
Journal:  Drug Alcohol Rev       Date:  2011-05

5.  Smokers with opioid use disorder may have worse drug use outcomes after varenicline than nicotine replacement.

Authors:  Rosemarie A Martin; Damaris J Rohsenow; Jennifer W Tidey
Journal:  J Subst Abuse Treat       Date:  2019-06-10

6.  Rising morbidity and mortality in midlife among white non-Hispanic Americans in the 21st century.

Authors:  Anne Case; Angus Deaton
Journal:  Proc Natl Acad Sci U S A       Date:  2015-11-02       Impact factor: 11.205

7.  Patterns of abuse among unintentional pharmaceutical overdose fatalities.

Authors:  Aron J Hall; Joseph E Logan; Robin L Toblin; James A Kaplan; James C Kraner; Danae Bixler; Alex E Crosby; Leonard J Paulozzi
Journal:  JAMA       Date:  2008-12-10       Impact factor: 56.272

Review 8.  Prescription opioid abuse: a literature review of the clinical and economic burden in the United States.

Authors:  Roxanne Meyer; Anisha M Patel; Stacy K Rattana; Tiffany P Quock; Samir H Mody
Journal:  Popul Health Manag       Date:  2014-12       Impact factor: 2.459

9.  Prescription Opioid Use, Misuse, and Use Disorders in U.S. Adults: 2015 National Survey on Drug Use and Health.

Authors:  Beth Han; Wilson M Compton; Carlos Blanco; Elizabeth Crane; Jinhee Lee; Christopher M Jones
Journal:  Ann Intern Med       Date:  2017-08-01       Impact factor: 25.391

10.  Differences in opioid prescribing in low back pain patients with and without depression: a cross-sectional study of a national sample from the United States.

Authors:  Joyce A Smith; Robert L Fuino; Irena Pesis-Katz; Xueya Cai; Bethel Powers; Maria Frazer; John D Markman
Journal:  Pain Rep       Date:  2017-06-22
View more
  1 in total

1.  Differences in the attitudes towards the opioid crisis between metropolitan and rural counties in Central Texas: Secondary data analysis using cross-sectional data.

Authors:  Marcia G Ory; Shinduk Lee; Matthew Lee Smith; Joy P Alonzo; Heather R Clark; James N Burdine
Journal:  Prev Med Rep       Date:  2022-03-08
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.